Versor Investments LP Purchases New Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Versor Investments LP acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm acquired 1,628 shares of the biotechnology company's stock, valued at approximately $651,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. PFG Investments LLC grew its holdings in Axon Enterprise by 0.6% during the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company's stock valued at $1,547,000 after purchasing an additional 25 shares during the last quarter. Gladstone Institutional Advisory LLC grew its holdings in Axon Enterprise by 1.6% in the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company's stock worth $656,000 after purchasing an additional 26 shares during the last quarter. Mather Group LLC. increased its holdings in shares of Axon Enterprise by 3.7% during the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company's stock valued at $303,000 after acquiring an additional 27 shares in the last quarter. CWM LLC raised its stake in Axon Enterprise by 1.3% in the 3rd quarter. CWM LLC now owns 2,856 shares of the biotechnology company's stock worth $1,141,000 after acquiring an additional 36 shares during the last quarter. Finally, SPC Financial Inc. raised its position in Axon Enterprise by 2.2% during the 3rd quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company's stock worth $708,000 after buying an additional 38 shares during the last quarter. Institutional investors own 79.08% of the company's stock.

Insiders Place Their Bets

In related news, CEO Patrick W. Smith sold 80,300 shares of the business's stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the sale, the chief executive officer now directly owns 3,015,366 shares in the company, valued at $1,121,052,771.48. The trade was a 2.59 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Joshua Isner sold 25,811 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total value of $9,287,830.24. Following the sale, the president now owns 228,166 shares in the company, valued at approximately $82,103,253.44. This trade represents a 10.16 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 411,006 shares of company stock valued at $161,360,618. 6.10% of the stock is owned by company insiders.

Axon Enterprise Stock Performance

Shares of AXON traded up $3.27 during mid-day trading on Thursday, hitting $604.56. 726,404 shares of the company's stock were exchanged, compared to its average volume of 550,267. The firm has a market capitalization of $46.10 billion, a P/E ratio of 156.22, a P/E/G ratio of 14.95 and a beta of 0.94. Axon Enterprise, Inc. has a fifty-two week low of $220.77 and a fifty-two week high of $624.84. The business's 50 day moving average is $433.89 and its two-hundred day moving average is $355.28. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Craig Hallum lifted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the company a "buy" rating in a research note on Wednesday, August 7th. The Goldman Sachs Group boosted their price target on Axon Enterprise from $385.00 to $441.00 and gave the company a "buy" rating in a report on Wednesday, October 23rd. Robert W. Baird raised their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an "outperform" rating in a research note on Monday, November 4th. Northland Securities lifted their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an "outperform" rating in a report on Monday. Finally, Needham & Company LLC increased their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a report on Friday, November 8th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of "Moderate Buy" and an average target price of $427.83.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.